Loading insider details...
Beta
Latest Form 4 (Aug 19, 2026): Exercise/Conversion of 5,000 TVTX shares, $87.2K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 19, 2026 | Travere Therapeutics, Inc. (TVTX) | Exercise/Conversion | 5,000 | $87.2K |
| May 29, 2026 | NEUROCRINE BIOSCIENCES INC (NBIX) | Grant/Award | 1,284 | n/a |
| May 21, 2026 | NEUROCRINE BIOSCIENCES INC (NBIX) | Exercise/Conversion | 1,659 | n/a |
| May 21, 2026 | Travere Therapeutics, Inc. (TVTX) | Grant/Award | 4,000 | n/a |
| Apr 16, 2026 | Travere Therapeutics, Inc. (TVTX) | Exercise/Conversion | 8,000 | $130.6K |
| Dec 4, 2025 | NEUROCRINE BIOSCIENCES INC (NBIX) | Exercise/Conversion | 15,000 | $718.4K |
| May 22, 2025 | NEUROCRINE BIOSCIENCES INC (NBIX) | Exercise/Conversion | 1,435 | n/a |
| May 16, 2025 | Travere Therapeutics, Inc. (TVTX) | Grant/Award | 6,500 | n/a |
| Oct 4, 2024 | Travere Therapeutics, Inc. (TVTX) | Exercise/Conversion | 40,000 | $419.2K |
| Aug 15, 2024 | NEUROCRINE BIOSCIENCES INC (NBIX) | Exercise/Conversion | 11,570 | $494.7K |